83 FR 55376 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 214 (November 5, 2018)

Page Range		55376-55377
FR Document		2018-24103

Federal Register, Volume 83 Issue 214 (Monday, November 5, 2018)

[Federal Register Volume 83, Number 214 (Monday, November 5, 2018)]
[Notices]
[Pages 55376-55377]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-24103]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Cardiovascular Disease.
    Date: November 13, 2018.
    Time: 2:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 55377]]

    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Luis Espinoza, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD 20892, 301-435-
0952, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; The Lasker Clinical Research Scholar Program.
    Date: November 28, 2018.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Abdelouahab Aitouche, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4222, MSC 7814, Bethesda, MD 
20892, 301-435-2365, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: Cancer Health Disparities.
    Date: November 29, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Reigh-Yi Lin, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, 301-827-6009, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: Cancer Health Disparities.
    Date: November 29-30, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Ola Mae Zack Howard, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4192, MSC 7806, Bethesda, MD 
20892, 301-451-4467, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: October 30, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-24103 Filed 11-2-18; 8:45 am]
 BILLING CODE 4140-01-P

55376 Federal Register / Vol. 83, No. 214 / Monday, November 5, 2018 / Notices

would constitute a clearly unwarranted Room 7009, 6707 Democracy Boulevard, this notice. The statement should include the
invasion of personal privacy. Bethesda, MD 20892–5452, 301–594–4721, name, address, telephone number and when
Kozelp@niddk.nih.gov. applicable, the business or professional
Name of Committee: National Institute on affiliation of the interested person.
Drug Abuse Special Emphasis Panel; (Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes, In the interest of security, NIH has
Quantification of Drugs of Abuse and Related instituted stringent procedures for entrance
Compounds in Biological Specimens (8951). Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition onto the NIH campus. All visitor vehicles,
Date: December 6, 2018. including taxicabs, hotel and airport shuttles
Time: 11:00 a.m. to 1:00 p.m. Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes will be inspected before being allowed on
Agenda: To review and evaluate contract
of Health, HHS) campus. Visitors will be asked to show one
proposals.
form of identification (for example, a
Place: National Institutes of Health, Dated: October 30, 2018. government-issued photo ID, driver’s license,
Neuroscience Center, 6001 Executive David D. Clary,
Boulevard, Rockville, MD 20852 (Telephone or passport) and to state the purpose of their
Conference Call). Program Analyst, Office of Federal Advisory visit.
Contact Person: Lyle Furr, Scientific Committee Policy. Information is also available on the
Review Officer, Office of Extramural Affairs, [FR Doc. 2018–24098 Filed 11–2–18; 8:45 am] Institute’s/Center’s home page: http://
National Institute on Drug Abuse, NIH, acd.od.nih.gov, where an agenda and any
BILLING CODE 4140–01–P
DHHS, Room 4227, MSC 9550, 6001 additional information for the meeting will
Executive Boulevard, Bethesda, MD 20892– be posted when available.
9550, (301) 827–5702, lf33c.nih.gov. DEPARTMENT OF HEALTH AND (Catalogue of Federal Domestic Assistance
(Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research
HUMAN SERVICES Training Award; 93.22, Clinical Research
Program No.: 93.279, Drug Abuse and
Addiction Research Programs, National Loan Repayment Program for Individuals
National Institutes of Health from Disadvantaged Backgrounds; 93.232,
Institutes of Health, HHS)
Loan Repayment Program for Research
Dated: October 30, 2018. Office of the Director, National Generally; 93.39, Academic Research
Natasha M. Copeland, Institutes of Health; Notice of Meeting Enhancement Award; 93.936, NIH Acquired
Program Analyst, Office of Federal Advisory Pursuant to section 10(a) of the Immunodeficiency Syndrome Research Loan
Committee Policy. Federal Advisory Committee Act, as Repayment Program; 93.187, Undergraduate
[FR Doc. 2018–24100 Filed 11–2–18; 8:45 am] Scholarship Program for Individuals from
amended, notice is hereby given of a Disadvantaged Backgrounds, National
BILLING CODE 4140–01–P meeting of the Advisory Committee to Institutes of Health, HHS)
the Director, National Institutes of
Health. Dated: October 30, 2018.
DEPARTMENT OF HEALTH AND The meeting will be open to the Natasha M. Copeland,
HUMAN SERVICES public, with attendance limited to space Program Analyst, Office of Federal Advisory
available. Individuals who plan to Committee Policy.
National Institutes of Health
attend and need special assistance, such [FR Doc. 2018–24097 Filed 11–2–18; 8:45 am]

National Institute of Diabetes and as sign language interpretation or other BILLING CODE 4140–01–P

Digestive and Kidney Diseases; Notice reasonable accommodations, should
of Closed Meeting notify the Contact Person listed below
in advance of the meeting. DEPARTMENT OF HEALTH AND
Pursuant to section 10(d) of the HUMAN SERVICES
Name of Committee: Advisory Committee
Federal Advisory Committee Act, as to the Director, National Institutes of Health.
amended, notice is hereby given of the National Institutes of Health
Date: December 13, 2018.
following meeting. Time: 8:30 a.m. to 5:30 p.m.
The meeting will be closed to the Center for Scientific Review; Notice of
Agenda: NIH Director’s Report, ACD
public in accordance with the Working Group Reports, Other Business of Closed Meetings
provisions set forth in sections the Committee. Pursuant to section 10(d) of the
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Place: National Institutes of Health. Federal Advisory Committee Act, as
as amended. The grant applications and Building 31, 6th Floor Conference Room 6C,
31 Center Drive, Bethesda, MD 20892.
amended, notice is hereby given of the
the discussions could disclose following meetings.
Contact Person: Gretchen Wood, Staff
confidential trade secrets or commercial The meetings will be closed to the
Assistant, National Institutes of Health,
property such as patentable material, Office of the Director, One Center Drive, public in accordance with the
and personal information concerning Building 1, Room 126, Bethesda, MD 20892, provisions set forth in sections
individuals associated with the grant 301–496–4272, Woodgs@od.nih.gov. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
applications, the disclosure of which Name of Committee: Advisory Committee as amended. The grant applications and
would constitute a clearly unwarranted to the Director, National Institutes of Health. the discussions could disclose
invasion of personal privacy. Date: December 14, 2018. confidential trade secrets or commercial
Name of Committee: National Institute of Time: 9:00 a.m. to 12:30 p.m. property such as patentable material,
Diabetes and Digestive and Kidney Diseases Agenda: ACD Working Group Reports, and personal information concerning
Special Emphasis Panel; NIDDK SEP: RC2. Other Business of the Committee. individuals associated with the grant
Date: November 19, 2018. Place: National Institutes of Health,
Building 31, 6th Floor Conference Room 6C,
applications, the disclosure of which
Time: 2:00 p.m. to 3:30 p.m. would constitute a clearly unwarranted
Agenda: To review and evaluate grant 31 Center Drive, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff invasion of personal privacy.
applications.
Place: National Institutes of Health, Two Assistant, National Institutes of Health, Name of Committee: Center for Scientific
Democracy Plaza, 6707 Democracy Office of the Director, One Center Drive, Review Special Emphasis Panel;
Boulevard, Bethesda, MD 20892 (Telephone Building 1, Room 126, Bethesda, MD 20892, Cardiovascular Disease.
Conference Call) 301–496–4272, Woodgs@od.nih.gov. Date: November 13, 2018.
Contact Person: Peter J. Kozel, Ph.D., Any interested person may file written Time: 2:00 p.m. to 4:00 p.m.
Scientific Review Officer, Review Branch, comments with the committee by forwarding Agenda: To review and evaluate grant
DEA, NIDDK, National Institutes of Health, the statement to the Contact Person listed on applications.

VerDate Sep<11>2014 18:38 Nov 02, 2018 Jkt 247001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\05NON1.SGM 05NON1

Federal Register / Vol. 83, No. 214 / Monday, November 5, 2018 / Notices 55377

Place: National Institutes of Health, 6701 DEPARTMENT OF HEALTH AND 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Rockledge Drive, Bethesda, MD 20892 HUMAN SERVICES as amended. The grant applications and
(Telephone Conference Call). the discussions could disclose
Contact Person: Luis Espinoza, Ph.D., National Institutes of Health confidential trade secrets or commercial
Scientific Review Officer, Center for property such as patentable material,
Scientific Review, National Institutes of National Institute on Drug Abuse; and personal information concerning
Health, 6701 Rockledge Drive, Room 4140, Notice of Closed Meeting individuals associated with the grant
MSC 7814, Bethesda, MD 20892, 301–435–
Pursuant to section 10(d) of the applications, the disclosure of which
0952, espinozala@mail.nih.gov.
Federal Advisory Committee Act, as would constitute a clearly unwarranted
This notice is being published less than 15 invasion of personal privacy.
days prior to the meeting due to the timing amended, notice is hereby given of the
limitations imposed by the review and following meeting of the Board of Name of Committee: National Institute on
funding cycle. Scientific Counselors, NIDA. Drug Abuse Special Emphasis Panel
The meeting will be closed to the Identification of Genetic and Genomic
Name of Committee: Center for Scientific Variants by Next-Gen Sequencing in Non-
Review Special Emphasis Panel; The Lasker
public as indicated below in accordance
with the provisions set forth in section human Animal Models (U01).
Clinical Research Scholar Program. Date: November 16, 2018.
Date: November 28, 2018. 552b(c)(6), Title 5 U.S.C., as amended Time: 1:00 p.m. to 3:00 p.m.
Time: 1:00 p.m. to 3:00 p.m. for the review, discussion, and Agenda: To review and evaluate
Agenda: To review and evaluate grant evaluation of individual intramural cooperative agreement applications.
applications. programs and projects conducted by the Place: National Institutes of Health,
Place: National Institutes of Health, 6701 National Institute on Drug Abuse, Neuroscience Center, 6001 Executive
Rockledge Drive, Bethesda, MD 20892 including consideration of personnel Boulevard, Rockville, MD 20852, (Telephone
(Virtual Meeting). qualifications and performance, and the Conference Call).
Contact Person: Gerald L. McLaughlin,
Contact Person: Abdelouahab Aitouche, competence of individual investigators, Ph.D., Scientific Review Officer, Office of
Ph.D., Scientific Review Officer, Center for the disclosure of which would Extramural Policy and Review, National
Scientific Review, National Institutes of constitute a clearly unwarranted Institute on Drug Abuse, NIH, DHHS, 6001
Health, 6701 Rockledge Drive, Room 4222, invasion of personal privacy. Executive Blvd., Room 4238, MSC 9550,
MSC 7814, Bethesda, MD 20892, 301–435– Bethesda, MD 20892–9550, 301–827–5819,
Name of Committee: Board of Scientific
2365, aitouchea@csr.nih.gov. gm145a@nih.gov.
Counselors, NIDA.
Name of Committee: Center for Scientific Date: December 3–4, 2018. Name of Committee: National Institute on
Review Special Emphasis Panel; PAR Panel: Closed: 8:00 a.m. to 5:00 p.m. Drug Abuse Special Emphasis Panel PHASE
Cancer Health Disparities. Agenda: To review and evaluate personal II Interview: NIDA Avant-Garde Award
Date: November 29, 2018. qualifications and performance, and Program for HIV/AIDS and Drug Use
Time: 8:00 a.m. to 5:00 p.m. competence of individual investigators. Research (DP1).
Agenda: To review and evaluate grant Place: Intramural Research Program, Date: December 10, 2018.
applications. National Institute on Drug Abuse, NIH, Johns Time: 8:00 a.m. to 5:00 p.m.
Hopkins Bayview Campus, Baltimore, MD Agenda: To review and evaluate grant
Place: Hilton Washington/Rockville, 1750
21223. applications.
Rockville Pike, Rockville, MD 20852.
Contact Person: Joshua Kysiak, Program Place: Courtyard by Marriott Chevy Chase,
Contact Person: Reigh-Yi Lin, Ph.D., 5520 Wisconsin Avenue, Chevy Chase, MD
Scientific Review Officer, Center for Specialist, Biomedical Research Center,
20815.
Scientific Review, National Institutes of Intramural Research Program, National
Contact Person: Hiromi Ono, Ph.D.,
Health, 6701 Rockledge Drive, Bethesda, MD Institute on Drug Abuse, NIH, DHHS, 251
Scientific Review Officer, Office of
20892, 301–827–6009, lin.reigh-yi@nih.gov. Bayview Boulevard, Baltimore, MD 21224,
Extramural Policy and Review, National
443–740–2465, kysiakjo@nida.nih.gov.
Name of Committee: Center for Scientific Institute on Drug Abuse, National Institutes
Review Special Emphasis Panel; PAR Panel: (Catalogue of Federal Domestic Assistance of Health, DHHS, 6001 Executive Boulevard,
Program Nos.: 93.279, Drug Abuse and Room 4238, MSC 9550, Bethesda, MD 20892,
Cancer Health Disparities.
Addiction Research Programs, National 301–827–5820, hiromi.ono@nih.gov.
Date: November 29–30, 2018.
Institutes of Health, HHS) (Catalogue of Federal Domestic Assistance
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant Dated: October 30, 2018. Program Nos.: 93.279, Drug Abuse and
applications. Natasha M. Copeland, Addiction Research Programs, National
Place: Hilton Washington/Rockville, 1750 Institutes of Health, HHS)
Program Analyst, Office of Federal Advisory
Rockville Pike, Rockville, MD 20852. Committee Policy. Dated: October 30, 2018.
Contact Person: Ola Mae Zack Howard, [FR Doc. 2018–24099 Filed 11–2–18; 8:45 am] Natasha M. Copeland,
Ph.D., Scientific Review Officer, Center for Program Analyst, Office of Federal Advisory
BILLING CODE 4140–01–P
Scientific Review, National Institutes of Committee Policy.
Health, 6701 Rockledge Drive, Room 4192,
[FR Doc. 2018–24101 Filed 11–2–18; 8:45 am]
MSC 7806, Bethesda, MD 20892, 301–451–
DEPARTMENT OF HEALTH AND BILLING CODE 4140–01–P
4467, howardz@mail.nih.gov.
HUMAN SERVICES
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine; National Institutes of Health DEPARTMENT OF HEALTH AND
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
HUMAN SERVICES
National Institute on Drug Abuse;
93.846–93.878, 93.892, 93.893, National Notice of Closed Meetings National Institutes of Health
Institutes of Health, HHS)
Pursuant to section 10(d) of the Draft Report on Health Research and
Dated: October 30, 2018.
Federal Advisory Committee Act, as Development To Stem the Opioid
Natasha M. Copeland, amended, notice is hereby given of the
Program Analyst, Office of Federal Advisory Crisis: A Federal Roadmap; Request
following meetings. for Comments
Committee Policy. The meetings will be closed to the
[FR Doc. 2018–24103 Filed 11–2–18; 8:45 am] public in accordance with the AGENCY: National Institutes of Health,
BILLING CODE 4140–01–P provisions set forth in sections HHS.

VerDate Sep<11>2014 18:38 Nov 02, 2018 Jkt 247001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\05NON1.SGM 05NON1

Document Created: 2018-11-03 00:29:18
Document Modified: 2018-11-03 00:29:18

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		November 13, 2018.
FR Citation		83 FR 55376

83 FR 55376 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 214 (November 5, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health